Sociedad Americana de Hirudoterapia

Genómica y proteómica

Enfoques moleculares modernos en biología de sanguijuelas medicinales

Last Updated: March 5, 2026Reviewed by: Andrei Dokukin, MD

Last updated: March 14, 2026

Classical biochemistry identified approximately 30–40 bioactive components in medicinal leech SGSry gland secretion over several decades of painstaking protein purification. Modern “omics” technologies have revolutionized this picture: genome sequencing, transcriptomics, and mass spectrometry proteomics have now identified over 200 proteins in leech SGS, revealing an unexpectedly complex pharmacological arsenal and opening new avenues for drug discovery.

Ensamblajes genómicos

Kvist et al. (2020)

First comprehensive Hirudo medicinalis genome assembly. 19,929 scaffolds spanning 176.96 Mbp. Gene annotation identified 15 anticoagulation factors and 17 antihemostatic proteins — substantially more than the ~8 previously characterized by biochemistry. The assembly revealed gene duplication events in the hirudin and eglin gene families, suggesting functional diversification.

Genome Features

  • Assembly size: 176.96 Mbp (relatively compact for an invertebrate)
  • 19,929 scaffolds (fragmented — long-read sequencing needed)
  • 15 anticoagulation gene families identified
  • 17 antihemostatic gene families identified
  • Gene duplication in hirudin/eglin families
  • Repeat content: characteristic of lophotrochozoan genomes

Transcriptómica — Expresión génica de células salivales

Babenko et al. (2020)

RNA-seq analysis of salivary cells from three Hirudo species (H. medicinalis, H. orientalis, H. verbana). Co-authored by I.P. Baskova, linking classical biochemistry with modern genomics. The study revealed species-specific expression differences in salivary genes — a finding with practical implications, since different species may produce quantitatively different SGS profiles and therefore exhibit different clinical potencies.

Guan et al. (2024)

Investigated starvation-induced changes in the salivary proteome and transcriptome. Leeches upregulate specific anticoagulant and tissue-penetration genes during prolonged fasting, optimizing SGS composition for the next feeding event. This finding explains the traditional practice of using “hungry” leeches in clinical application — they produce a more potent and complex secretion.

Proteómica — Era de la espectrometría de masas

Liu et al. (2019)

Comprehensive proteomic analysis using LC-MS/MS identified 434 full-length protein sequences in Hirudo saliva, of which 44 were confirmed bioactive through functional assays. This represents a 10-fold increase over the classical biochemistry inventory.

Novel ClassFunctionDrug Discovery Potential
M12/M13 ProteasesMetalloprotease tissue remodelingWound healing, anti-fibrotic
CRISP ProteinsCysteine-rich secretory proteins; immune modulationAnti-inflammatory leads
ApyraseADP hydrolysis; antiplateletAntiplatelet drug leads
Adenosine DeaminaseAdenosine metabolism; vasodilationCardiovascular modulation
CystatinsCysteine protease inhibitionAnti-inflammatory, antiparasitic
FicolinsLectin complement pathway activationInnate immunity modulation

Avances en biología estructural

Tandem-Hirudin (Hohmann et al., 2022)

Discovery of the first oligomeric hirudin — a hirudin variant that forms tandem multimers. Unlike classical hirudin, tandem-hirudin shows no direct thrombin inhibitory activity, suggesting a novel, as-yet-uncharacterized biological function. This finding challenges the assumption that all hirudin family members are anticoagulants.

Destabilase Crystal Structure (Zavalova et al., 2023)

Crystal structure of destabilase resolved at 1.1 Angstrom resolution — the highest-resolution structure of any leech salivary protein. The structure revealed a revised catalytic mechanism for isopeptidase activity, clarifying how destabilase cleaves cross-linked fibrin through a mechanism distinct from classical lysozyme catalysis.

De ~30 a más de 200 proteínas identificadas

Paradigm Shift

Classical biochemistry (1950s–2000s) identified approximately 30–40 bioactive components through painstaking individual protein purification. Modern omics approaches have expanded this to over 200 identified proteins. The majority remain functionally uncharacterized — each representing a potential drug lead or biological insight into the most pharmacologically complex animal secretion known.

Direcciones futuras

Single-Cell Transcriptomics

scRNA-seq of individual salivary gland cells will reveal which cell types produce which SGS components, enabling targeted manipulation of specific bioactive pathways.

CRISPR Functional Studies

Gene knockout/knockdown in leech SGSry cells will establish definitive gene–function relationships for the hundreds of uncharacterized salivary proteins identified by proteomics.

Synthetic Biology

Recombinant production of individual SGS components or designed multi-component cocktails could enable standardized, leech-free delivery of specific therapeutic combinations.

Recursos relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.